Record quarterly revenue came in well ahead of estimates on 13% growth in Tyvaso DPI, yet earnings missed because a $130 million nondeductible charge for the Thymmune acquisition pushed the tax rate to 31% from 23%. The miss traces to that pipeline bill rather than demand, and management just authorized another $2.0 billion buyback.
Latest Activity
UTHR Coverage
Buy, Sell, or Hold? Monday’s Top Upgrades and Downgrades: Advanced Micro Devices, Airbnb, DraftKings, L3 Harris Technologies, Molson-Coors, Nvidia, Take-Two Interactive, Uber Technologies, and More
Pre-Market Stock Futures: Futures are trading higher after a wild week that saw stocks rally after the election, then the Nasdaq post its biggest loss in 18 months on Thursday before rebounding…
United Therapeutics and Liquidia Just Ended Their Patent War. Liquidia Stock Popped 42%
A patent court ruling wiped out nearly half of Liquidia's stock value in a single day, and the settlement that followed cost the company almost every dollar it had in the bank.…
United Therapeutics Won Its Patent War and Liquidia Collapsed
A single court ruling sent one pulmonary hypertension drugmaker soaring and left its rival fighting for survival, but the legal battle over Yutrepia's future is far from settled.
Here Are Thursday’s Top Wall Street Analyst Research Calls: BP, Dollar Tree, Exxon Mobil, Lennar, Occidental Petroleum, Rocket Lab, Teva Pharmaceuticals, United Therapeutics, and More
Pre-Market Stock Futures: Futures are trading higher after the bulls charged early Wednesday after the August CPE inflation report came in better than expected. But by the close, the tech-heavy Nasdaq was…
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alcoa, Chiron Real Estate, Clear Secure, Fortinet, Fresh Pet, Kennametal, Oracle, PayPal, United Therapeutics, and More
Pre-Market Stock Futures: Futures are trading modestly higher after a blowout midweek rally spurred by reports that a peace agreement with Iran could be forthcoming soon and by incredible technology earnings and…
Here Are Friday’s Top Wall Street Analyst Research Calls: Autodesk, Delek US Holdings, Insmed, Nike, Nutanix, ServiceNow, Shake Shack, Southern Copper, Veeva Systems, and More
Pre-Market Stock Futures: The futures are trading mixed as we approach the end of one of the most volatile and wild trading weeks in recent memory. After starting the day lower on…
United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo
United Therapeutics (NASDAQ:UTHR | UTHR Price Prediction) surged more than 12% in pre-market trading on March 30 after positive TETON-1 trial data triggered price target raises from two major Wall Street firms.…
Tuesday’s Top Analyst Upgrades and Downgrades: CrowdStrike, DoorDash, Etsy, JetBlue, Marriott, Silvergate Capital and More
Tuesday's top analyst upgrades and downgrades included CrowdStrike, Diamondback Energy, DoorDash, Etsy, JetBlue Airways, Lululemon Athletica, Marriott International and Silvergate Capital.
Tuesday’s Top Analyst Upgrades and Downgrades: Adobe, Huntsman, Kraft Heinz, NCR, Peloton, Take-Two and Many More
Tuesday's top analyst upgrades and downgrades included Adobe, Cheniere Energy, CNX Resources, Edwards Lifesciences, EOG Resources, Huntsman, Kraft Heinz, NCR, Peloton Interactive, PulteGroup, Take-Two Interactive Software and UDR.
Tuesday’s Top Analyst Upgrades and Downgrades: Altria, American Air, Bumble, Chevron, Datadog, GM, Mastercard, Pinduoduo, Regeneron, Tesla, TotalEnergies and More
Tuesday's top analyst upgrades and downgrades included Accenture, Altria, American Airlines, APA, Bumble, Chevron, Datadog, General Motors, Mastercard, Pinduoduo, Regeneron Pharmaceuticals, Tesla, Toast and TotalEnergies.
7 Large Biotechs Expected to Outperform This Earnings Season
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic…
Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Cree, Etsy, Gilead, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems, Virgin Galactic and More
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Cree, Etsy, Gilead Sciences, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems and Virgin Galactic.
How Biotech and Big Pharma Have Upside Heading Into Earnings
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Top Analyst Upgrades and Downgrades: Apple, Carnival, Generac, Lyft, Six Flags, Square, Tecnoglass, Yum Brands, Western Digital, Zoetis and More
The top analyst upgrades, downgrades and initiations on Monday included Apple, Carnival, Generac, Lyft, Six Flags, Square, Tecnoglass, Yum! Brands, Western Digital and Zoetis.
Top Analyst Upgrades and Downgrades: American Eagle, Atlassian, Match, NextEra, Nordstom, Office Depot, Roku, Stamps.com, Tanger and More
The top analyst upgrades, downgrades and initiations seen on Thursday included American Eagle Outfitters, Atlassian, Match, NextEra Energy, Nordstom, Office Depot, Roku, Stamps.com and Tanger Factory Outlet Centers.